OPEN & ENROLLING TRIALS

DAASH - Ongoing and enrolling

This is a pilot study to investigate the effectiveness of HCV treatment with velpatasvir/sofosbuvir administered by psychiatrist/licensed buprenorphine/naloxone providers during regularly scheduled visits to an outpatient addiction clinic for buprenorphine/naloxone replacement therapy and mental healthcare, as measured by percentage of patients achieving SVR-12 (defined as HCV RNA < lower limit of quantification (LLOQ) 12 weeks after discontinuation of study treatment.)

For more information, please contact: Community Research Initiative of New England Research Team, 617.502.1707 or info@crine.org

If you would like updates about new, enrolling trials, please fill out the contact form below. Your information will be kept strictly confidential by our research staff.